Skip to content

Member

András Tivadar KULJA

EPP · Hungary

Group
EPP PPE
Country
Hungary
Roll-call participation
61.2 %ⓘ of 5 928 roll calls in office · chamber median 90.2 % · whole term, roll calls
With majority line
86.4 %ⓘ of 3 628 votes where the group had a line · EPP median 93.6 %
More facts (5)
National party
TISZA Tisztelet és Szabadság Párt
In office
Since 16 Jul 2024
Against clear line
387 of 3 470 votesⓘ
Committees
ENVI (vice-chair), SANT
Member id
256864
More

Record

The member’s figures against the median of their group and of the chamber. Each vote counts the member in the group they belonged to that day.

Roll-call participation ⓘ

61.2 %

3 628 of 5 928 roll calls while in office

EPP median: 89.9 % (−28.7 pts)

Chamber median: 90.2 %

With majority line ⓘ

86.4 %

3 133 of 3 628 votes where their group had a line

EPP median: 93.6 % (−7.3 pts)

Against clear line ⓘ

11.2 %

387 of 3 470 votes where their group had a clear line

184 opposite (for ↔ against), 200 abstained against the line, 3 voted for or against when the line was to abstain

Abstention ⓘ

7.3 %

266 of 3 628 votes cast

Participation 61.2 % — EPP median 89.9 %, 196 members.ⓘ
Data as a table
Participation among the 196 members of the EPP with enough votes.
FigureParticipation
András Tivadar KULJA61.2 %
EPP median89.9 %
Lowest in the group17.0 %
Highest in the group99.6 %
Members196
With majority line 86.4 % — EPP median 93.6 %, 196 members.ⓘ
Data as a table
With majority line among the 196 members of the EPP with enough votes.
FigureWith majority line
András Tivadar KULJA86.4 %
EPP median93.6 %
Lowest in the group70.2 %
Highest in the group99.5 %
Members196
  • Whole term, 5 928 roll-call votes. The dots are the other members of EPP; no ranks.
  • “No vote recorded” is not the same as absent: leave, illness and chairing the sitting look the same.
  • A group’s line is inferred from its members’ votes — Parliament publishes no whip.

Votes, 620

Export

Every final roll-call vote of the term with the member’s position, newest first.

Result: for–against–abstained. Majority line: how most of the member’s group voted that day (“Tie” when no position won). ≠ group marks a vote otherwise than a clear line (at least two thirds, with at least 10 members voting) of their group.
DateDecisionResultPositionMajority line
17 Sept 2026Deteriorating situation of media freedom and freedom of expression in Hong Kong following the recent arrest of bookseller Leticia Wong and the convictions of Lee Cheuk-yan and Chow Hang-tung Adopted 459 for, 12 against, 86 abstainedPosition: For Majority line: For
17 Sept 2026Political prisoners in Cuba, in particular the case of Félix Navarro and his daughter Saylí Navarro Adopted 374 for, 198 against, 19 abstainedPosition: For Majority line: For
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector Adopted 514 for, 61 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Post-electoral repression in Zambia and the killing of Mutotwe Kafwaya Adopted 562 for, 1 against, 33 abstainedPosition: For Majority line: For
17 Sept 2026Impact of social media and the online environment on young people Adopted 395 for, 136 against, 80 abstainedPosition: For Majority line: For
17 Sept 2026The role of social, economic and environmental standards in safeguarding fair competition for all aquatic food products and improving food security Adopted 467 for, 92 against, 44 abstainedPosition: For Majority line: For
17 Sept 2026Evaluation of the Common Fisheries Policy and follow-up Adopted 368 for, 172 against, 69 abstainedPosition: For Majority line: For
17 Sept 2026Narco-trafficking in Europe’s waters: protecting our borders and supporting our law enforcement officers Adopted 601 for, 4 against, 5 abstainedPosition: For Majority line: For
17 Sept 2026The recent hybrid attacks and instrumentalisation of migrants in Ceuta and the need for a coordinated response to protect EU’s external borders Adopted 339 for, 225 against, 16 abstainedPosition: For Majority line: For
17 Sept 2026Strengthening global health resilience in partner countries Adopted 319 for, 142 against, 19 abstainedPosition: For Majority line: For
16 Sept 2026Simplification of intra-EU transfers of defence-related products and simplification of security and defence procurement (Omnibus V) Passed 549 for, 92 against, 27 abstainedPosition: For Majority line: For
16 Sept 2026Acceleration of permit-granting for defence readiness projects (Omnibus V) Passed 540 for, 105 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026Defence readiness and facilitating defence investments and conditions for the defence industry (Omnibus V) Passed 530 for, 125 against, 12 abstainedPosition: For Majority line: For
16 Sept 2026Establishing the Single Market and Customs Programme for the period 2028-2034 Passed 496 for, 53 against, 125 abstainedPosition: For Majority line: For
16 Sept 2026Instrument for Nuclear Safety Cooperation 2028-2034 Passed 600 for, 21 against, 48 abstainedPosition: For Majority line: For
16 Sept 2026Nuclear decommissioning assistance programme of the Ignalina nuclear power plant in Lithuania for the period 2028-2034 Passed 625 for, 20 against, 22 abstainedPosition: For Majority line: For
16 Sept 2026EU-Switzerland Agreement on the transfer of passenger name record (PNR) data for the prevention, detection, investigation and prosecution of terrorist offences and serious crime Consent given 549 for, 75 against, 30 abstainedPosition: For Majority line: For
16 Sept 2026EU-UK Agreement regarding cooperation on the application of their respective competition laws Consent given 640 for, 5 against, 26 abstainedPosition: For Majority line: For
16 Sept 2026EU-Iceland Agreement on the participation of Iceland in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 631 for, 7 against, 15 abstainedPosition: For Majority line: For
16 Sept 2026EU-Norway Agreement on the participation of Norway in GOVSATCOM and in the Union Secure Connectivity Programme Consent given 612 for, 8 against, 16 abstainedPosition: For Majority line: For
16 Sept 2026Genetically modified soybean GMB151 x DAS-44406-6 Objection passed 442 for, 184 against, 12 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Genetically modified soybean MON 94313 Objection passed 457 for, 184 against, 10 abstainedPosition: For ≠ groupMajority line: Against
16 Sept 2026Genetically modified maize MON 87460 Objection passed 433 for, 159 against, 10 abstainedPosition: For Majority line: Against
16 Sept 2026Hybrid warfare and the protection of the EU’s territorial integrity and critical security and defence infrastructure Adopted 470 for, 129 against, 62 abstainedPosition: For Majority line: For
16 Sept 2026An EU cardiovascular diseases strategy Adopted 545 for, 47 against, 75 abstainedPosition: For Majority line: For
16 Sept 2026Gender inequalities in health, specifically as regards gender-specific conditions Adopted 390 for, 218 against, 29 abstainedPosition: For Majority line: Against
15 Sept 2026Carbon Border Adjustment Mechanism: extension of its scope to downstream goods and anti-circumvention measures Passed 464 for, 50 against, 159 abstainedPosition: For Majority line: For
15 Sept 2026Establishing the Temporary Decarbonisation Fund Passed 433 for, 97 against, 146 abstainedPosition: Abstained ≠ groupMajority line: For
15 Sept 2026Market stability reserve for the EU Emissions Trading System (EU ETS): ceasing the invalidation of allowances Passed 367 for, 240 against, 59 abstainedPosition: For Majority line: For
15 Sept 2026Market stability reserve for the buildings, road transport and additional sectors Passed 467 for, 158 against, 41 abstainedPosition: For Majority line: For
15 Sept 2026Implementation into Union law of measures adopted by regional fisheries management organisations Passed 559 for, 48 against, 62 abstainedPosition: For Majority line: For
15 Sept 2026General Fisheries Commission for the Mediterranean (GFCM): fishing in the GFCM Agreement area Passed 580 for, 51 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Temporary trade-liberalisation measures applicable to Armenian products Passed 583 for, 49 against, 39 abstainedPosition: For Majority line: For
15 Sept 2026Draft amending budget No 2/2026: update of revenue (own resources) and adjustments to expenditure Passed 440 for, 127 against, 104 abstainedPosition: No vote recorded Majority line: For
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield Adopted 420 for, 220 against, 26 abstainedPosition: For Majority line: For
15 Sept 2026Implementation of the Council Recommendation on a Bridge to Jobs – Reinforcing the Youth Guarantee Adopted 530 for, 77 against, 61 abstainedPosition: For Majority line: For
15 Sept 2026The EU Youth Strategy 2019–2027 Adopted 477 for, 124 against, 66 abstainedPosition: For Majority line: For
15 Sept 2026Global role of the euro Adopted 405 for, 146 against, 60 abstainedPosition: For Majority line: For
9 Jul 2026Establishment of the digital euro Negotiating mandate approved 416 for, 169 against, 22 abstainedPosition: For Majority line: For
9 Jul 2026The threat of war crimes, the escalating violations of international humanitarian law and the human rights situation in El-Obeid, Sudan Adopted 476 for, 28 against, 96 abstainedPosition: For Majority line: For
9 Jul 2026Ongoing persecution of Christians in Nigeria, notably the Kawel village massacre Adopted 510 for, 1 against, 86 abstainedPosition: For Majority line: For
9 Jul 2026Feasibility of a 28th tax regime and its potential to support EU competitiveness Adopted 366 for, 192 against, 39 abstainedPosition: For Majority line: For
8 Jul 2026EU–Mexico Political, Economic and Cooperation Strategic Partnership Agreement Consent given 479 for, 119 against, 65 abstainedPosition: For Majority line: For
8 Jul 2026Protection of the environment through criminal law Consent given 499 for, 99 against, 69 abstainedPosition: For Majority line: For
8 Jul 2026EU–Mexico Interim Agreement on Trade Consent given 474 for, 131 against, 60 abstainedPosition: For Majority line: For
8 Jul 2026EU–Morocco Euro-Mediterranean Aviation Agreement: accession to the EU of Croatia (Protocol) Consent given 625 for, 16 against, 20 abstainedPosition: For Majority line: For
8 Jul 2026EU-Morocco Agreement for scientific and technological cooperation setting out the terms and conditions for the participation of Morocco in the Partnership for Research and Innovation in the Mediterranean Area (PRIMA): amendment and supplement Consent given 573 for, 35 against, 37 abstainedPosition: For Majority line: For
8 Jul 2026Trajectory to decrease the contribution of high indirect land-use change-risk biofuels, bioliquids and biomass fuels to renewable energy targets Objection passed 388 for, 248 against, 24 abstainedPosition: For Majority line: For
8 Jul 2026Lead in certain fishing tackle Objection failed 197 for, 455 against, 7 abstainedPosition: Against Majority line: Against
8 Jul 2026Genetically modified maize NK603 × T25 Objection passed 460 for, 189 against, 14 abstainedPosition: For Majority line: Against

Roll-call participation

One cell per sitting while in office, shaded by the share of that day’s roll calls the member voted in. The official attendance register is kept separately by Parliament.

No vote recorded on 24 of 107 sittings with roll calls.

"No vote recorded" is not the same as absent: leave, illness and chairing the sitting look the same.

Data as a table
Roll calls held at each sitting while in office and how many of them the member voted in.
SittingRoll callsVoted in
17 Jul 20242323
18 Jul 202411
16 Sept 202422
18 Sept 202422
19 Sept 20249292
7 Oct 202422
8 Oct 202411
9 Oct 20241818
10 Oct 202444
21 Oct 202422
22 Oct 20241010
23 Oct 2024129129
24 Oct 20241312
13 Nov 202422
14 Nov 20243636
25 Nov 202421
26 Nov 20241818
27 Nov 20241111
28 Nov 2024570
17 Dec 20241311
18 Dec 20243332
19 Dec 2024456
20 Jan 202522
21 Jan 202511
22 Jan 202522
23 Jan 20254540
10 Feb 202510
11 Feb 20253232
12 Feb 20251010
13 Feb 20253026
10 Mar 202522
11 Mar 202590
12 Mar 2025228172
13 Mar 20252422
31 Mar 202530
1 Apr 20253535
2 Apr 202525160
3 Apr 20256254
5 May 202555
6 May 2025103
7 May 2025220181
8 May 202510388
21 May 202522
22 May 20255328
16 Jun 202520
17 Jun 2025410
18 Jun 2025910
19 Jun 2025870
7 Jul 202510
8 Jul 20255529
9 Jul 2025134101
10 Jul 20253635
8 Sept 202511
9 Sept 202510191
10 Sept 20253431
11 Sept 20256923
6 Oct 202522
7 Oct 202555
8 Oct 20255547
9 Oct 20256547
20 Oct 202531
21 Oct 20251313
22 Oct 2025186142
23 Oct 2025550
13 Nov 2025267209
24 Nov 202531
25 Nov 20257522
26 Nov 202510080
27 Nov 202512590
15 Dec 202544
16 Dec 20256620
17 Dec 2025430
18 Dec 20254227
20 Jan 20266740
21 Jan 20261125
22 Jan 2026580
9 Feb 202620
10 Feb 20263830
11 Feb 20261312
12 Feb 20261410
24 Feb 2026430
9 Mar 202610
10 Mar 20261970
11 Mar 2026600
12 Mar 2026340
25 Mar 202630
26 Mar 2026691
27 Apr 202620
28 Apr 20262250
29 Apr 2026296254
30 Apr 20266858
18 May 202644
19 May 202633
20 May 20269695
21 May 20269897
15 Jun 202620
16 Jun 20264037
17 Jun 2026127121
18 Jun 20267776
6 Jul 202620
7 Jul 20267267
8 Jul 2026144108
9 Jul 20266767
14 Sept 202611
15 Sept 2026155149
16 Sept 20268078
17 Sept 2026124124

Voting neighbours

Members who voted the same way most often in the roll calls they both took part in, within and outside the member’s group (group at the date of each vote), over all roll calls of the term.

At least 200 shared roll calls over at least six months in office together. Within = both sat in the same group on the date of the vote; a member who changed group can appear on both lists. Baseline = the median agreement of all pairs of members of the groups the two sat in on the date of each shared vote (within: the group they shared; outside: the two groups), weighted by the votes they shared in each combination.

Within EPP

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in the same group (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of that group.
SelectMemberGroupCountryAgreementBaseline
Eszter LAKOS EPPHungary99 % of 3 274 shared89 %
Dóra DÁVID EPPHungary99 % of 3 586 shared89 %
Gabriella GERZSENYI EPPHungary99 % of 2 356 shared89 %
Kinga KOLLÁR EPPHungary99 % of 3 067 shared89 %
Zoltán TARR Former memberEPPHungary97 % of 1 796 shared89 %
Péter MAGYAR Former memberEPPHungary93 % of 682 shared89 %
Willemien KONING EPPNetherlands89 % of 1 213 shared89 %
Marie-Sophie CHRIST EPPGermany88 % of 1 291 shared89 %
Manfred WEBER EPPGermany88 % of 2 850 shared89 %
Martine KEMP EPPLuxembourg87 % of 2 916 shared89 %

Show all 10 neighbours

Outside the group

Agreement: roll calls where both cast the same position, of the roll calls both voted in while in different groups (“shared”); a count below 50 shared. Baseline: the median agreement of every pair of members of the groups the two sat in on those votes (groups at the date, weighted by the votes shared in each combination).
SelectMemberGroupCountryAgreementBaseline
Jérémy DECERLE RenewFrance79 % of 1 750 shared82 %
Ivars IJABS RenewLatvia78 % of 2 812 shared82 %
Sophie WILMÈS RenewBelgium78 % of 2 466 shared82 %
Urmas PAET RenewEstonia78 % of 3 122 shared82 %
Hilde VAUTMANS RenewBelgium78 % of 3 514 shared82 %
Nathalie LOISEAU RenewFrance78 % of 2 822 shared82 %
Eugen TOMAC RenewRomania77 % of 2 398 shared82 %
Gilles BOYER RenewFrance77 % of 3 612 shared82 %
Benoit CASSART RenewBelgium77 % of 3 409 shared82 %
Grégory ALLIONE RenewFrance77 % of 3 203 shared82 %

Show all 10 neighbours

Work

Seats in committees, delegations and intergroups, and the dossiers the member leads, shadows or negotiates.

Seats

Body: the committee, delegation or intergroup, with its kind. Role: the member’s role in it. From, To: the dates of the seat (“now” while it lasts).
BodyRoleFromTo
Committee on the Environment, Climate and Food SafetyENVI CommitteeVice-chair20 Jan 2025now
Committee on Public HealthSANT CommitteeMember23 Jan 2025now
Delegation for relations with CanadaD-CA DelegationSubstitute12 Jun 2026now
Delegation for relations with the Korean PeninsulaDKOR DelegationSubstitute19 Sept 2024now
Intergroup on Anti-CorruptionIG10-01 Intergroup / working groupMember16 Jan 2025now
Intergroup on Cancer and Rare DiseasesIG10-05 Intergroup / working groupMember27 Jan 2025now
Intergroup on DisabilityIG10-10 Intergroup / working groupMember11 Mar 2025now
Intergroup on Mental HealthIG10-17 Intergroup / working groupMember5 Feb 2025now
Intergroup on Traditional Minorities, National Communities and LanguagesIG10-25 Intergroup / working groupMember5 Feb 2025now
Committee on Employment and Social AffairsEMPL CommitteeSubstitute19 Jul 202411 Jun 2026

Show all 13 seats

Dossiers

Dossier: the procedure the declaration names (“No dossier named” for a delegation without one). Role: rapporteur, shadow rapporteur, negotiator or delegation. Committee: the committee that appointed them. Date: of the declaration.
DossierRoleCommitteeDate
No dossier namedOfficial delegationSANT2 Sept 2026
No dossier namedOfficial delegationSANT22 Apr 2026
No dossier namedOfficial delegationSANT29 Jan 2026
An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sectorShadow rapporteurSANT8 Oct 2025
Laying a framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest, and amending Regulation (EU) 2024/795Shadow rapporteur for an opinionENVI19 Jun 2025
No dossier namedOfficial delegationENVI17 Mar 2025
Implementation and delivery of the Sustainable Development Goals in view of the 2025 High-Level Political ForumShadow rapporteurENVI24 Feb 2025
Safety of toysShadow rapporteur for an opinionENVI14 Nov 2024
No dossier namedOfficial delegation25 Oct 2024
No dossier namedOfficial delegation11 Sept 2024
No dossier namedCommittee vice-chairENVI20 Jul 2024

Topics they work on (model-assigned)

Counts: dossiers they spoke on, led or amended, and their questions and motions.

In the chamber

Speeches and statements in plenary debates, newest first; the verbatim report is on Parliament’s site.

38 contributions recorded, 2 written statements; 4 on behalf of their group; 52 minutes of speaking time.

Date: the sitting. Debate: the item debated, and the group when they spoke on its behalf. Kind: speech or written statement, with speaking time. Verbatim: the verbatim report on Parliament’s site.
DateDebateKindVerbatim
17 Sept 2026Protecting people’s health against toxic substances (debate) Speech · 1 minRead
17 Sept 2026An EU health workforce crisis plan: sustainability of healthcare systems and employment and working conditions in the healthcare sector (debate) on behalf of EPPSpeech · 2 minRead
15 Sept 2026Findings and recommendations of the Special Committee on the European Democracy Shield (debate) Speech · 1 minRead
15 Sept 2026Devastating heatwaves, wildfires and droughts in Europe: lessons from summer 2026 (debate) Speech · 1 minRead
11 Feb 2026Rule of law, fundamental rights and misuse of EU funds in Slovakia: the need for an EU response (debate) Speech · 1 minRead
19 Jan 2026Framework for strengthening the availability and security of supply of critical medicinal products as well as the availability of, and accessibility of, medicinal products of common interest (debate) on behalf of EPPSpeech · 2 minRead
16 Dec 2025Presentation of the EU Cardiovascular Health Plan (debate) Speech · 1 minRead
16 Dec 2025Presentation of the EU Cardiovascular Health Plan (debate) Speech · 2 minRead
15 Dec 2025Impact of the geopolitical situation on European patients and their access to medicines (debate) Speech · 2 minRead
23 Oct 2025Breast cancer: the importance of screening (debate) StatementRead

Show all 38 recent contributions

Questions and motions, 14

Parliamentary questions and motions for resolutions the member authored or co-signed, newest first.

Date: tabled. Title: the question or motion, with its id. Kind: written question or motion for a resolution, with the number of co-authors. Answer: the date of the answer to a question.
DateTitleKindAnswer
18 May 2026Access to reliable clinical performance data and regulatory oversight of CGM systems in the EU E-10-2026-002029Written question17 Jul 2026
11 Feb 2026Request for an assessment of land confiscation practices and of the criminalisation of public criticism of historical legislation in Slovakia P-10-2026-000603Priority written questionwith 6 co-authors30 Apr 2026
22 Dec 2025Serious concerns regarding compliance with European values and EU law in Slovakia E-10-2025-005054Written questionwith 12 co-authors21 Apr 2026
20 Dec 2025Implementation of EU anti-poverty strategy based on accurate data E-10-2025-005037Written questionwith 5 co-authors25 Feb 2026
23 Sept 2025Newborn screening for access to advanced life-saving therapies E-10-2025-003675Written questionwith 3 co-authors21 Nov 2025
17 Jun 2025The role of local authorities in addressing the financial and operational challenges posed by PFAS and other persistent chemical contaminants in Europe E-10-2025-002429Written questionwith 20 co-authors26 Aug 2025
29 Apr 2025Strengthening workplace health and safety to prevent sudden cardiac arrest deaths E-10-2025-001716Written question13 Jun 2025
26 Feb 2025Rare diseases P-10-2025-000845Priority written questionwith 7 co-authors2 May 2025
21 Feb 2025Commission’s response to the incomplete implementation of the UN Convention on the Rights of Persons with Disabilities in Member States E-10-2025-000810Written questionwith 50 co-authors27 May 2025
20 Jan 2025Infection prevention and action against antimicrobial resistance, including innovative therapies E-10-2025-000213Written question18 Mar 2025

Show all 14 questions and motions

Amendments tabled in committee, 52

Committee amendment documents that carry amendments by the member, with how many are theirs.

Date: of the amendment document. Text amended: the dossier and the document’s id. Committee: where the amendments were tabled. Amendments: how many in the document are the member’s.
DateText amendedCommitteeAmendments
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792014 SANT26
11 Sept 2026Modernised rules for patients’ rights in cross-border healthcare SANT-AM-792154 SANT5
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791891 SANT3
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791887 SANT9
28 Jul 2026Amending Regulations (EU) 2017/745 and (EU) 2017/746 as regards simplifying and reducing the burden of the rules on medical devices and in vitro diagnostic medical devices, and amending Regulation (EU) 2022/123 as regards the support of the European Medicines Agency for the expert panels on medical devices and Regulation (EU) 2024/1689 as regards the list of Union harmonisation legislation referred to in its Annex I SANT-AM-791890 SANT1
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790936 CJ535
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790937 CJ539
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790938 CJ531
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790939 CJ536
13 Jul 2026Establishing a framework of measures for strengthening Union’s biotechnology and biomanufacturing sectors particularly in the area of health and amending Regulations (EC) No 178/2002, (EC) No 1394/2007, (EU) No 536/2014, (EU) 2019/6, (EU) 2024/795 and (EU) 2024/1938 (European Biotech Act) CJ53-AM-790934 CJ536

Show all 52 amendment documents

Connections

Dossiers they lead or shadow, committees, party, delegation and other related pages.

Political group

National delegation

  • Delegation Hungary National delegation

Sources & citation

Where the facts on this page come from, and how to cite it.

Data source
Licensed CC BY 4.0.
Data version
data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1 · methods
Retrieved
25 September 2026

Cite as

EU Parl Watch Research (2026). “András Tivadar KULJA”. Member record. memberId 256864. EU Parl Watch Research. https://news.eu-parl.st-solutions.dev/members/256864?roles=all&rows=all&scope=all (retrieved 25 September 2026). Official source: Member’s profile, European Parliament, https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record, https://data.europarl.europa.eu/api/v2/meps/256864?format=application%2Fld%2Bjson (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1.
BibTeX
@misc{epw-member-256864,
  author = {{EU Parl Watch Research}},
  title = {{András Tivadar KULJA}},
  year = {2026},
  howpublished = {\url{https://news.eu-parl.st-solutions.dev/members/256864?roles=all&rows=all&scope=all}},
  url = {https://news.eu-parl.st-solutions.dev/members/256864?roles=all&rows=all&scope=all},
  urldate = {2026-09-25},
  publisher = {EU Parl Watch Research},
  note = {Member record. memberId 256864. Official source: https://www.europarl.europa.eu/meps/en/256864. Data: EP Open Data: member record (CC BY 4.0); data version f37e5638cded (25 Sept 2026) · methods: group-at-date v1, participation v1, abstention v1, loyalty v1, against-clear v1, cohesion v1, agreement v1, group-agreement v1, winning-side v1, similar-votes v1, scope v1, data-version v1}
}